TickerFacts.

Anavex Life Sciences Corp. (AVXL): Total Liabilities

Annual figures by period end, from SEC filings.

$8.95M
As of 2025-09-30
$7.69M
As of 2026-06-30
-4.3%
3-year compound annual growth
+4.1%
5-year compound annual growth
+12.9%
10-year compound annual growth
$15.30M2010-09-30: $3.29M2011-09-30: $1.35M2012-09-30: $2.89M2013-09-30: $2.86M2014-09-30: $7.16M2015-09-30: $2.66M2016-09-30: $3.19M2017-09-30: $3.58M2019-09-30: $5.04M2020-09-30: $7.31M2021-09-30: $10.80M2022-09-30: $10.21M2023-09-30: $12.53M2024-09-30: $15.30M2025-09-30: $8.95M$8.95M
2010-09-30 Total Liabilities (USD) 2025-09-30
Period endedTotal LiabilitiesChange YoYSource filing
2025-09-30$8.95M-41.5%2026-08-28, Balance as of period end
2024-09-30$15.30M+22.1%2026-08-28, Balance as of period end
2023-09-30$12.53M+22.7%2024-12-23, Balance as of period end
2022-09-30$10.21M-5.4%2023-11-27, Balance as of period end
2021-09-30$10.80M+47.8%2022-11-28, Balance as of period end
2020-09-30$7.31M+45.0%2021-11-24, Balance as of period end
2019-09-30$5.04Mn/a2020-12-28, Balance as of period end
No annual figure between 2017-09-30 and 2019-09-30.
2017-09-30$3.58M+12.3%2017-12-11, Balance as of period end
2016-09-30$3.19M+19.9%2017-12-11, Balance as of period end
2015-09-30$2.66M-62.8%2016-12-14, Balance as of period end
2014-09-30$7.16M+150.7%2015-12-29, Balance as of period end
2013-09-30$2.86M-1.1%2014-12-29, Balance as of period end
2012-09-30$2.89M+114.7%2013-12-30, Balance as of period end
2011-09-30$1.35M-59.1%2012-12-31, Balance as of period end
2010-09-30$3.29Mn/a2011-12-22, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Anavex Life Sciences Corp. (AVXL)2025-09-30$8.95M-41.5%
Surrozen, Inc. (SRZN)2025-12-31$286.49M+310.2%
Lineage Cell Therapeutics, Inc. (LCTX)2025-12-31$69.24M+91.2%
Zura Bio Ltd (ZURA)2025-12-31$12.41M-36.4%
IRulya Therapeutics Inc. (IRLA)2025-12-31$129.24M+53.2%
Humacyte, Inc. (HUMA)2025-12-31$113.26M-40.6%
LeonaBio, Inc. (LONA)2025-12-31$64.36M+361.8%
Aligos Therapeutics, Inc. (ALGS)2025-12-31$34.99M-64.7%
Kalaris Therapeutics, Inc. (KLRS)2025-12-31$42.92M-24.4%

Compare AVXL, SRZN, LCTX, ZURA side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗